Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS -- Ignore unavailable to you. Want to Upgrade?

To: Deeber who wrote (239)	1/31/1999 3:46:00 PM
From: Nescom	Respond to of 518

A friend of mine received this from IR. Re: Financing The company will be completing a private $1 million financing next week which will enable them to begin the clinical trials on humans at Hammersmith in England and also at the Mass General Hospital in Boston almost immediately. Once we have the results from the first few treatments, we will release them to the world. A second financing should follow shortly thereafter, probably $5+ million which will give the company enough assets to apply for a Nasdaq small-cap listing. I believe the company needs to do about 100 cases which should take about 18 months or so. Initially treatments will be done on 10 women that will have to forego a masectomy anyway. A complete examination of the area where the tumor existed will be examined. If there are no signs of cancer in three months, the cancerous tumor is considered ablated (according to the FDA's definition). When, and I do pray for when, we finally get these results, Celsion will be on the cover of every newspaper in the world. Geoff Eiten, Investor Relations www.celsion.com